CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands |
9 Months Ended |
Jan. 29, 2017 |
Jan. 31, 2016 |
| Cash flows from operating activities: |
|
|
|
| Net income |
$ 16,136
|
|
$ 13,333
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
| Depreciation |
5,304
|
|
4,888
|
| Amortization of assets |
162
|
|
123
|
| Stock-based compensation |
2,619
|
|
1,964
|
| Excess tax benefit related to stock-based compensation |
(195)
|
|
(822)
|
| Deferred income taxes |
3,533
|
|
1,906
|
| Realized loss on sale of short-term investments |
12
|
|
127
|
| Gain on sale of equipment |
(71)
|
|
(66)
|
| Foreign currency exchange gains |
(18)
|
|
(85)
|
| Changes in assets and liabilities: |
|
|
|
| Accounts receivable |
340
|
|
1,091
|
| Inventories |
(137)
|
|
(6,485)
|
| Other current assets |
90
|
|
(108)
|
| Other assets |
51
|
|
48
|
| Accounts payable - trade |
(946)
|
|
(1,979)
|
| Accrued expenses and deferred compensation |
(948)
|
|
1,406
|
| Income taxes |
(1,695)
|
|
535
|
| Net cash provided by operating activities |
24,237
|
|
15,876
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(9,253)
|
|
(7,686)
|
| Investment in unconsolidated joint venture |
(600)
|
|
|
| Proceeds from the sale of equipment |
80
|
|
230
|
| Payment on life insurance policy |
(18)
|
|
(18)
|
| Proceeds from the sale of short-term investments |
2,000
|
|
5,612
|
| Purchase of short-term investments |
(8)
|
|
(86)
|
| Purchase of long-term investments (Held-To-Maturity) |
(31,050)
|
|
|
| Purchase of long-term investments (Rabbi Trust) |
(1,431)
|
|
(1,268)
|
| Net cash used in investing activities |
(40,280)
|
|
(3,216)
|
| Cash flows from financing activities: |
|
|
|
| Proceeds from line of credit |
7,000
|
|
7,000
|
| Payments on line of credit |
(7,000)
|
|
(7,000)
|
| Payments on vendor-financed capital expenditures |
(1,050)
|
|
|
| Payments on long-term debt |
|
|
(2,200)
|
| Excess tax benefit related to stock-based compensation |
195
|
|
822
|
| Repurchase of common stock |
|
|
(2,397)
|
| Dividends paid |
(5,292)
|
|
(7,281)
|
| Payments on debt issuance costs |
(2)
|
|
(43)
|
| Proceeds from common stock issued |
37
|
|
138
|
| Net cash used in financing activities |
(6,112)
|
|
(10,961)
|
| Effect of exchange rate changes on cash and cash equivalents |
27
|
|
289
|
| (Decrease) increase in cash and cash equivalents |
(22,128)
|
|
1,988
|
| Cash and cash equivalents at beginning of period |
37,787
|
[1] |
29,725
|
| Cash and cash equivalents at end of period |
$ 15,659
|
|
$ 31,713
|
|
|